The non-WNT/non-SHH (Grp3/Grp4) medulloblastomas (MBs) comprise eight second-generation subgroups (SGS; I–VIII) each with distinct molecular and clinical characteristics [2, 7, 10]. Here, RASGRP3 is linked to medulloblastoma.